Amarin buys privately held Israeli Ester Neurosciences for $32m

Ester Neurosciences logoAnother Israeli exit in the biotech sector. Clinical research firm Amarin agreed to acquire Israel-based privately held research and development company Ester Neurosciences for an initial $15m (€10.2m), in addition to $17m (€11.5m) in contingent payments.

Ester Neurosciences Ltd. is a development stage biopharmaceutical company committed to the discovery and development of novel therapeutic products for the treatment of neurological disorders such as myasthenia gravis, Alzheimer’s disease, multiple sclerosis and acute stress reactions. Ester’s unique platform technology is based on the company’s breakthrough discoveries relating to cholinergic neuromodulation and its involvement in the diseased state. Ester was led by Prof. Eli Hazum, and founded in 1997. [via]

 

Follow me
Co Founder and Managing Partner at Remagine Ventures
Eze is managing partner of Remagine Ventures, a seed fund investing in ambitious founders at the intersection of tech, entertainment, gaming and commerce with a spotlight on Israel.

I'm a former general partner at google ventures, head of Google for Entrepreneurs in Europe and founding head of Campus London, Google's first physical hub for startups.

I'm also the founder of Techbikers, a non-profit bringing together the startup ecosystem on cycling challenges in support of Room to Read. Since inception in 2012 we've built 11 schools and 50 libraries in the developing world.
Eze Vidra
Follow me
Total
0
Shares
Previous Article

The Next-Israeli "Killer Application for Facebook" Challenge

Next Article

VC investments around the globe hit a high of six years, including Israel

Related Posts
Read More

Desperate VC

Source: Dilbert Author Recent Posts Follow meEze VidraCo Founder and Managing Partner at Remagine VenturesEze is managing partner…
Total
0
Share